The Motley Fool
Positive
9/18 10:13 PM
3 Dividend Stocks to Buy and Hold for 10 Years
Pfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term. Abbott Laboratories' core medical device business remains strong, and the company has attractive opportunities elsewhere.
The Motley Fool
Positive
9/17 7:23 PM
Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?
Medtronic has an above-average dividend yield. The company is expanding its robotic-assisted surgery capabilities.
Zacks Investment Research
Positive
9/17 2:11 PM
BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?
Boston Scientific faces near-term pressure in electrophysiology, while Medtronic gains share and sees stronger momentum across key franchises.
PRNewsWire
Neutral
9/16 10:30 AM
Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system
Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) has cleared the LigaSure™ RAS Maryland jaw device for use with the Hugo™ robotic-assisted surgery (RAS) system.
MarketBeat
Positive
9/16 12:03 AM
Medtronic Sees AI, Ablation and Targeted M&A Fueling Growth
Medtronic NYSE: MDT Chief Financial Officer Thierry Piéton said the medical-device maker's focus on acute procedures, expanding innovation pipeline and increased use of targeted acquisitions are supporting its recent growth momentum.
Seeking Alpha
Neutral
9/15 11:01 PM
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
PRNewsWire
Neutral
9/14 11:30 AM
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax purposes GALWAY, Ireland, Sept. 14, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced that it has commenced an exchange offer to split off at least 80.1% of the shares of MiniMed Group, Inc. (MiniMed; Nasdaq: MMED).
PRNewsWire
Neutral
9/14 11:30 AM
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection with Medtronic plc's ("Medtronic"; NYSE: MDT) offer to exchange up to 225,361,295 shares of MiniMed common stock, representing 80.1% of the total outstanding shares of MiniMed common stock, for outstanding Medtronic ordinary shares that are validly tendered and not validly withdrawn.
24/7 Wall Street
Neutral
9/13 2:36 PM
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one.
Market Watch
Neutral
9/10 10:02 PM
Here are the stocks to favor in the fourth quarter — and those you should avoid
Large caps tend to outperform small caps as year's end approaches.
52W Range
$73.31 - $106.33
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
